Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06175390
Title Tiragolumab, Atezolizumab and Chemotherapy in Triple Negative Breast Cancer (SKYLINE)
Acronym SKYLINE
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Institut Curie
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Institut Curie RECRUITING Paris 92210 France Details
Institut Curie RECRUITING Saint-Cloud 92210 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field